NESTLE’S health unit on Tuesday (Jun 25) launched a Web platform to provide nutritional support for individuals on weight loss programmes, including those using GLP-1 medications.
Nestle Health Science said the website will address specific needs such as preserving lean muscle mass, supporting gut health, and offering personalised diet assistance.
As more people use GLP-1 drugs for weight control, several telehealth companies have started offering services to support these individuals.
In June, Kroger Health, the division of the grocery chain Kroger that operates pharmacies and clinics across the US, revamped its weight management programme to offer patients access to medical treatments such as Wegovy, Zepbound and others.
Health and wellness platform Hims & Hers Health in May also added compounded versions of GLP-1 injections to its comprehensive weight loss portfolio
GLP-1 medications have recently become popular and are in strong demand in the US These drugs, including Novo Nordisk’s Ozempic and Wegovy, were initially developed to treat type two diabetes but also help with weight loss by suppressing appetite and promoting fullness.
A NEWSLETTER FOR YOU
Friday, 2 pm
Lifestyle
Our picks of the latest dining, travel and leisure options to treat yourself.
However, there have been intermittent shortages over the past year, with makers such as Novo Nordisk and Eli Lilly, which makes Mounjaro racing to ramp up supply.
The growing use of these drugs has led experts to project annual global sales of about US$150 billion by the early 2030s. REUTERS
